A new oral GLP-1 medication called aleniglipron produced an average 12 percent body weight reduction over 36 weeks in clinical trials, addressing a major public health challenge affecting billions globally. The drug works by stimulating insulin secretion, suppressing appetite, and increasing satiety, offering a non-injection alternative to existing GLP-1 therapies.
The Hill · Sunday, 28 June 2026
The study found that the drug stimulates insulin secretion, suppresses appetite and increases satisfaction to promote weight loss.
Original source
Read the full article at The HillShare this story
Volunteer physicians in La Guaira rapidly repurposed a fast-food restaurant to provide medical care following a seismic event, extending healthcare access when conventional facilities were unavailable. The improvised clinic demonstrates community resilience and medical innovation in resource-constrained conditions.
Al Jazeera · 11 Jul
Pakistan's Supreme Court issued comprehensive anti-harassment guidelines for educational institutions and upheld strict penalties against a headmistress who failed to protect female teachers from sexual harassment. The ruling requires all schools to adopt internal harassment policies, establish independent complaint mechanisms, and display codes of conduct across the country.
Dawn Pakistan · 11 Jul
Brazil's Amazon deforestation fell to its lowest level in ten years, reflecting strengthened enforcement against illegal logging and forest clearing. The milestone supports Lula's commitment to eliminate illegal deforestation by 2030, with implications for global climate and biodiversity.
Al Jazeera · 10 Jul
Every Sunday — the week's most uplifting stories, straight to your inbox. No doom, no noise.
No spam. Unsubscribe anytime. GDPR compliant.